Intraductal papillary mucinous neoplasm (IPMN) of the pancreas: recommendations for Standardized Imaging and Reporting from the Society of Abdominal Radiology IPMN disease focused panel

Abdom Radiol (NY). 2021 Apr;46(4):1586-1606. doi: 10.1007/s00261-020-02853-4. Epub 2020 Nov 13.

Abstract

There have been many publications detailing imaging features of malignant transformation of intraductal papillary mucinous neoplasms (IPMN), management and recommendations for imaging follow-up of diagnosed or presumed IPMN. However, there is no consensus on several practical aspects of imaging IPMN that could serve as a clinical guide for radiologists and enable future data mining for research. These aspects include how to measure IPMN, define reporting terminology, standardize reporting and unify guidelines for surveillance. The Society of Abdominal Radiology (SAR) created multiple Disease-Focused Panels (DFP) comprised multidisciplinary panel members who focus on a particular disease, with the goal to develop ways for radiologists to improve patient care, education, and research. DFP members met to identify the current controversies and limitations of imaging pancreatic IPMN. This paper aims to provide a practical review of the key imaging characteristics of IPMN for trainees and practicing radiologists, to guide uniformity of performance and interpretation of surveillance imaging studies, and to improve communication with clinicians by providing a lexicon and reporting template based on the experience of the SAR-DFP panel members.

Keywords: Computed tomography; Intraductal papillary mucinous neoplasm; MRCP; Pancreas; Surveillance; Template.

Publication types

  • Review

MeSH terms

  • Humans
  • Pancreas
  • Pancreatic Intraductal Neoplasms* / diagnostic imaging
  • Pancreatic Neoplasms* / diagnostic imaging
  • Radiography, Abdominal
  • Radiology*